G. Naim

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Impact of Early Limitation of Therapeutic Effort in Elderly COVID-19 Patients Admitted to the Intensive Care Unit—A Cohort Study

B. Mégarbane, N. Deye, S. Voicu, 2022, Journal of personalized medicine.

Cytological patterns of bronchoalveolar lavage fluid in mechanically ventilated COVID‐19 patients on extracorporeal membrane oxygenation

B. Mégarbane, N. Deye, H. Adle-Biassette, 2022, The clinical respiratory journal.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients

A. Mebazaa, B. Mégarbane, E. Gayat, 2020, Journal of Infection.

Dismal Survival in COVID-19 Patients Requiring ECMO as Rescue Therapy after Corticosteroid Failure

B. Mourvillier, B. Mégarbane, N. Deye, 2021, Journal of personalized medicine.

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study

J. Chiche, Y. Castier, P. Demondion, 2021, The Lancet Respiratory Medicine.

Outcome of Critically Ill COVID-19 Patients According to the Setting of Corticosteroid Initiation—A Retrospective Observational Cohort Study

B. Mégarbane, N. Deye, S. Voicu, 2021, Journal of personalized medicine.